Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Identification of CXCR4 domains that support coreceptor and chemokine receptor functions.

J Virol. 1999 Apr;73(4):2752-61. Unique Identifier : AIDSLINE MED/99173969
Doranz BJ; Orsini MJ; Turner JD; Hoffman TL; Berson JF; Hoxie JA; Peiper SC; Brass LF; Doms RW; Department of Pathology and Laboratory Medicine, Department of; Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; 19104, USA.


Abstract: The interaction of the chemokine stromal cell-derived factor 1 (SDF-1) with its receptor CXCR4 is vital for cell trafficking during development, is capable of inhibiting human immunodeficiency virus type 1 (HIV-1) utilization of CXCR4 as a coreceptor, and has been implicated in delaying disease progression to AIDS in vivo. Because of the importance of this chemokine-chemokine receptor pair to both development and disease, we investigated the molecular basis of the interaction between CXCR4 and its ligands SDF-1 and HIV-1 envelope. Using CXCR4 chimeras and mutants, we determined that SDF-1 requires the CXCR4 amino terminus for binding and activates downstream signaling pathways by interacting with the second extracellular loop of CXCR4. SDF-1-mediated activation of CXCR4 required the Asp-Arg-Tyr motif in the second intracellular loop of CXCR4, was pertussis toxin sensitive, and did not require the distal C-terminal tail of CXCR4. Several CXCR4 mutants that were not capable of binding SDF-1 or signaling still supported HIV-1 infection, indicating that the ability of CXCR4 to function as a coreceptor is independent of its ability to signal. Direct binding studies using the X4 gp120s HXB, BH8, and MN demonstrated the ability of HIV-1 gp120 to bind directly and specifically to the chemokine receptor CXCR4 in a CD4-dependent manner, using a conformationally complex structure on CXCR4. Several CXCR4 variants that did not support binding of soluble gp120 could still function as viral coreceptors, indicating that detectable binding of monomeric gp120 is not always predictive of coreceptor function.
Keywords: JOURNAL ARTICLE Amino Acid Sequence Cell Line Chemokines, CXC/*METABOLISM Human HIV Envelope Protein gp120/*METABOLISM Molecular Sequence Data Receptors, CXCR4/GENETICS/*METABOLISM Signal Transduction Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S.KWDjournalarticleaminoacidsequencecelllinechemokines,cxc/KWDmetabolismhumanhivenvelopeproteingp120/KWDmetabolismmolecularsequencedatareceptors,cxcr4/genetics/KWDmetabolismsignaltransductionsupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDs
990730
A9970813

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .